Compare Quest Diagnostics Inc (DGX) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| DGX | USIG | |
|---|---|---|
Market Cap | $26.21B | — |
Sector | Health | Fixed Income |
52-Week High | $238.50 | $52.69 |
52-Week Low | $173.49 | $50.18 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
